Cutera Inc (CUTR)
$18.12 0.19 (1.04%)
14:40 EDT CUTR Stock Quote Delayed 30 Minutes
Previous Close $18.31
Market Cap 247.06M
PE Ratio 9.24
Volume (Avg. Vol.) 118,746
Day's Range 17.95 - 18.50
52-Week Range 9.07 - 39.15
Dividend & Yield N/A (N/A)
CUTR Stock Predictions, Articles, and Cutera Inc News
- From InvestorPlace
- From the Web
These 10 stocks, including APHA, posted monster earnings. But are they still the best stocks to buy, or has the market now caught up?
Insider buying can shed light into a company's future performance. If the insiders are buying, it could be a bullish signal.
These 10 stocks don't look a thing alike, other than their esteemed position as some of the best stocks to buy as we're firmly in 2018's halfway point.
One thing is certain, healthcare isn’t going away.
These five top biotech stocks have the seal of approval from the Street, with 'strong buy' analyst consensus ratings and big upside.
With markets at all-time highs, some investors feel stocks are too expensive. But if they're wrong, these 10 stocks to buy should outperform.
From Market News Video
From Market News Video
The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company would choose to take their hard-earned cash and use it to buy stock in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both..
From Seeking Alpha
Gainers: Viveve Medical (NASDAQ:VIVE) +111%.VivoPower International (NASDAQ:VVPR) +57%.Sigma Labs (NASDAQ:SGLB) +27%.FTS International (NYSEMKT:FTSI) +25%.BigCommerce (NASDAQ:BIGC) +24%.Phoenix Tree (NYSE:DNK) +24%.Cutera (NASDAQ:CUTR) +18%.Jiayin (NASDAQ:JFIN) +18%.Organovo (NASDAQ:ONVO) +18%.Orchard Therapeutics (NASDAQ:ORTX) +17%.Losers: Sonnet BioTherapeutics (NASDAQ:SONN) -19%.Anixa Biosciences (NASDAQ:ANIX) -19%.YRC Worldwide (NASDAQ:YRCW) -18%.Children's Place (NASDAQ:PLCE) -17%.Lipocine (NASDAQ:LPCN) -16%.Velocity Financial (NYSE:VEL) -16%.ATIF Holdings (NASDAQ:ATIF) -15%.Proteostasis Therapeutics (NASDAQ:PTI) -14%.Liminal BioSciences (NASDAQ:LMNL) -13%.Kirkland's (NASDAQ:KIRK) -12%.
Navellier RatingsPowered by Portfolio Grader